FAF
REGN icon

Första AP-fonden’s Regeneron Pharmaceuticals REGN Stock Holding History

Första AP-fonden’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,380
Closed -$16.5M – 408
2025
Q4 		$16.5M Sell
21,380
-520
-2% -$353K 0.1% 179
2025
Q3 		$12.3M Buy
21,900
+800
+4% +$452K 0.07% 229
2025
Q2 		$11.1M Buy
21,100
+300
+1% +$167K 0.07% 231
2025
Q1 		$13.2M Sell
20,800
-1,300
-6% -$894K 0.1% 179
2024
Q4 		$15.7M Sell
22,100
-2,400
-10% -$2.01M 0.11% 161
2024
Q3 		$25.8M Buy
24,500
+2,200
+10% +$2.45M 0.2% 95
2024
Q2 		$23.4M Sell
22,300
-600
-3% -$582K 0.21% 89
2024
Q1 		$22M Buy
22,900
+2,900
+15% +$2.76M 0.19% 109
2023
Q4 		$17.6M Sell
20,000
-500
-2% -$412K 0.18% 114
2023
Q3 		$16.9M Buy
20,500
+200
+1% +$157K 0.19% 103
2023
Q2 		$14.6M Sell
20,300
-200
-1% -$154K 0.16% 133
2023
Q1 		$16.8M Sell
20,500
-4,700
-19% -$3.54M 0.2% 103
2022
Q4 		$18.2M Sell
25,200
-2,600
-9% -$1.92M 0.21% 105
2022
Q3 		$19.2M Sell
27,800
-400
-1% -$252K 0.23% 95
2022
Q2 		$16.7M Sell
28,200
-500
-2% -$325K 0.22% 101
2022
Q1 		$20M Sell
28,700
-2,200
-7% -$1.39M 0.23% 85
2021
Q4 		$19.5M Buy
30,900
+1,000
+3% +$615K 0.2% 100
2021
Q3 		$18.1M Buy
29,900
+1,800
+6% +$1.12M 0.21% 99
2021
Q2 		$15.7M Buy
28,100
+2,300
+9% +$1.17M 0.18% 117
2021
Q1 		$12.2M Buy
25,800
+4,600
+22% +$2.24M 0.17% 134
2020
Q4 		$10.2M Buy
21,200
+1,200
+6% +$648K 0.15% 147
2020
Q3 		$11.2M Buy
20,000
+6,400
+47% +$3.88M 0.23% 87
2020
Q2 		$8.48M Buy
13,600
+4,400
+48% +$2.5M 0.22% 107
2020
Q1 		$4.49M Buy
+9,200
New +$3.79M 0.16% 169

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Första AP-fonden's REGN Position: Q1 2026 in Review

Första AP-fonden sold out of Regeneron Pharmaceuticals (REGN) in Q1 2026, closing a stake of 21,380 shares — an estimated $16.5M sold.

Första AP-fonden first reported a position in REGN in Q1 2020 and held it in 24 quarters. The position peaked at $25.8M in Q3 2024. 1,400 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Första AP-fonden reported no remaining Regeneron Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Första AP-fonden sold 21,380 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $16.5M.
  • Första AP-fonden first reported a position in Regeneron Pharmaceuticals in Q1 2020 and held it in 24 quarters.
  • Första AP-fonden's Regeneron Pharmaceuticals position peaked at $25.8M in Q3 2024.
  • 1,400 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Första AP-fonden's 13F filing for Q1 2026.